CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FRIESEN, R. M.
Right arrow Articles by BONET, J. F.
Right arrow Search for Related Content
PubMed
Right arrow Articles by FRIESEN, R. M.
Right arrow Articles by BONET, J. F.

Canadian Journal of Anesthesia, Vol 30, 124-131, Copyright © 1983 by Canadian Anesthesiologists' Society

The Antiarrhythmic Effects of Verapamil and Propranolol in Aminophylline Toxic Dogs

ROBERT M. FRIESEN MD FRCP(C)1 and JORGE F. BONET MD FRCP(C)1

1 Department of Anaesthesia, Health Sciences Centre and the Department of Pharmacology & Therapeutics, Faculty of Medicine, University of Manitoba

Address Correspondence to: Dr. Robert M. Friesen, Department of Anaesthesia, St. Boniface General Hospital, 409 Taché Avenue, Winnipeg, Manitoba R2H 2A6

The antiarrhythmic effects of the calcium blocker verapamil and the beta adrenoreceptor blocker propranolol were examined in aminophylline toxic dogs. Eighteen dogs were intubated and ventilated after induction of anaesthesia (pentobarbitone 30 mg/kg and paccuronium 0.1 mg/kg). All animals were rendered toxic by aminophylline infusion; an initial dose of 50 mg/kg over five minutes with subsequent doses of 10 mg/kg over 30 seconds. Twenty minutes after each aminophylline infusion, the dog was challenged with phenylephrine (10 to 20 µg/kg). This resulted in short duration hypertension and reproducible emergence of ventricular arrhythmias. The dogs were divided into three groups of six animals each. Group I (control) received no antiarrhythmics whereas Group II received verapamil 0.2 mg/kg and Group III received propranolol 0.1 mg/kg for the treatment of persistent ventricular arrhythmias. Both verapamil and propranolol exerted an antiarrhythmic effect in aminophylline induced ventricular arrhythmias. The efficacy of verapamil was independent of the accompanying reduction in blood pressure and systemic vascular resistance as subsequent phenylephrine induced hypertension could not reinstitute these arrhythmias. Propranolol appeared less effective since it did not completely suppress the arrhythmias in three dogs and could not prevent emergence of PVC's in four following repeat phenylephrine challenge. Further developmentof this animal model may be useful for the better understanding of ventricular arrhythmias.

Key Words: TOXICITY: ventricular arrhythmias, aminophylline • HEART: antiarrhythmics • ANTIARRHYTHMICS: verapamil, propranolol






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1983 by the Canadian Anesthesiologists' Society.